Buprenorphine Hydrochloride Tablet
Product Images NDC 72888-509

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Buprenorphine Hydrochloride (NDC 72888-509). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advagen Pharma Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Buprenorphine Sublingual Tablets 2 mg (NDC 72888-182-30)

Packaging label for Buprenorphine Sublingual Tablets, 2 mg, containing 30 tablets. The label shows the product name, strength, route (sublingual), and dosage form (tablet). It includes the NDC number 72888-182-30, the labeler Advagen Pharma Ltd, and manufacturer Rubicon Research Pvt. Ltd. Additional text provides dosage guidance and storage instructions.*

FDA Label Image

Buprenorphine Sublingual Tablets 2 mg (NDC 72888-182-90)

Packaging label for Buprenorphine Sublingual Tablets, 2 mg, by Advagen Pharma Ltd. The label states the active ingredient amount, storage instructions, package size of 90 tablets, and includes distributor and manufacturer details from Advagen Pharma Ltd and Rubicon Research Pvt. Ltd. The label indicates prescription-only status and contains a barcode.*

FDA Label Image

Buprenorphine Sublingual Tablets 8 mg (NDC 72888-183-30)

Label for Buprenorphine Sublingual Tablets, 8 mg, showing product name, strength, dosage form, and quantity of 30 tablets. Label includes storage instructions, medication guide availability, distributor Advagen Pharma Ltd, and manufacturer Rubicon Research Pvt. Ltd. Barcode and NDC 72888-183-30 are visible.*

FDA Label Image

Buprenorphine Sublingual Tablets 8 mg (NDC 72888-183-90)

Label for Buprenorphine Sublingual Tablets, 8 mg strength, in a package of 90 tablets. The label states each tablet contains 8.64 mg buprenorphine hydrochloride USP equivalent to 8 mg buprenorphine base. It includes storage instructions, pharmacy dispensing warnings, and manufacturer information: Advagen Pharma Ltd as distributor and Rubicon Research Pvt. Ltd. as manufacturer. The label also references the medication guide availability online.*

FDA Label Image

Ifu-image (Buprenorphine Sublingual Tablets Ifu Image)

Illustration showing the proper placement of a sublingual tablet under the tongue using fingers. The drawing focuses on the mouth with an open jaw, highlighting the position of the tablet for sublingual administration.*

FDA Label Image

Chemical Structure (Buprenorphine Sublingual Tablets Structure)

Chemical structure diagram of buprenorphine hydrochloride, showing the molecular framework including rings, functional groups, and the HCl component.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.